U 75875
- CAS NO.：112190-24-6
- Empirical Formula: C45H61N7O7
- Molecular Weight: 812.00854
- MDL number: MFCD00902835
- SAFETY DATA SHEET (SDS)
What is U 75875?
The Uses of U 75875
U 75875, is a peptidomimetic inhibitor, that inhibits HIV-1 gag-pol protein. In human peripheral blood mononuclear cells and in a continuous cell line, U-75875 completely blocked HIV replication, so it can be used as therapeutic potential of protease inhibitors for treatment of HIV infection.
Properties of U 75875
| Boiling point: | 1158.5±65.0 °C(Predicted) |
| Density | 1?+-.0.06 g/cm3(Predicted) |
| pka | 12.71±0.46(Predicted) |
Safety information for U 75875
Computed Descriptors for U 75875
New Products
Cis-Tosylate Dibenzoyl-L-tartaric acid Anhydrous (Resolution Reagent) 2,6-Dipicolic Acid 1,2,3,9-Tetrahydro-9-Methyl-4H-Carbazole-4-One Dibenzo[b,f][1,4]thiazepin-11(10H)-one N-BOC-piperidine-4-carboxylic acid 1-Benzhydrylazetane-3-carbonitrile AMINO-(3-CHLORO-PHENYL)-ACETIC ACID 2-(2-Chlorophenyl)glycine (±)-amino(2-fluorophenyl)acetic acid 8-oxa-1,3-diazaspiro[4.5]decane-2,4-dione MEHYL AMINE-D3.HCL METHANE SULFONIC ACID-D4 PHOSPORIC ACID-D3 85 W% IN D2O DEUTERIUM OXIDE FOR NMR TOLUENE-D3 BENZENE-D6 1-(3-Chlorophenyl)piperazine hydrochlorideRelated products of tetrahydrofuran
You may like
-
7292-71-9 AMINO-(3-CHLORO-PHENYL)-ACETIC ACID 98+View Details
7292-71-9 -
84145-28-8 98+View Details
84145-28-8 -
2-(2-Chlorophenyl)glycine 98+View Details
88744-36-9 -
8-oxa-1,3-diazaspiro[4.5]decane-2,4-dione 39124-19-1 98+View Details
39124-19-1 -
7292-71-9 AMINO-(3-CHLORO-PHENYL)-ACETIC ACID 98+View Details
7292-71-9 -
84145-28-8 98+View Details
84145-28-8 -
2-(2-Chlorophenyl)glycine 98+View Details
88744-36-9 -
8-oxa-1,3-diazaspiro[4.5]decane-2,4-dione 39124-19-1 98+View Details
39124-19-1
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.